Two Tech Stocks for 2021
Stock 1 - Cybersecurity Tech:
Whitehawk (ASX:WHK) is our cybersecurity technology pick on the ASX. The WHK share price has looked like it wants to run over the last two trading sessions, rising from 30c to 38c on low volume and no news.
We suspect this might have something to do with the Biden inauguration... but obviously can’t be sure.
US based WHK provides cybersecurity tech to very large organisations, including the US government.
Newly inaugurated US President Joe Biden has already stated his intentions to focus on cybersecurity during his term.
2020 also gave rise to a cybersecurity breach of multiple US government departments that was described as “The hack of the decade”
This was part of a growing trend of hacks on government departments and large infrastructure businesses.
We believe cybersecurity tech solutions like those offered by WHK will become highly sought after in 2021.
Here is our opinion on how the US “hack of the decade” from December might impact WHK:
Stock 2 - Health Tech:
We are long term investors in MyFiziq (ASX: MYQ), which has developed an accessible, advanced human imaging by smartphone app for the med-health, population health, fitness and insurance sectors.
The MYQ price has spent the last 6 weeks consolidating around the $1.20 mark after a steady uptrend from 90c.
Over $7.8 trillion is spent on healthcare globally, so the rise of healthtech solutions has become a huge opportunity for investors.
MYQ was busy in 2020 and the distribution of its app into various partner technologies was reflected in the share price.
Today, MYQ announced that it will help partner Bearn Application expand its volume capability.
Bearn has over 56,000,000 users pre-registered for the combined application and is looking to increase platform capacity to allow mass onboarding. MYQ will provide $500,000 to do so, as the pair look to sign 1M monthly active users to the MYQ app.
We are long term investors in MYQ. here is why:
tagsNEXT TECH STOCK HEALTH TECH CYBERSECURITY TECHNOLOGY STOCKS ASX CYBERSECURITY TECHNOLOGY HEALTHCARE
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.